Biostar Pharma
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1633 Bayshore Hwy Ste 280, Burlingame, C...Phone Number
+86 1056315388Website
www.biostar-pharm.comRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Biostar Pharma
Beijing Huahao Zhongtian Biopharmaceutical Co., Ltd. is a comprehensive biopharmaceutical company focused on the research, development, production, and commercialization of innovative anti-tumor drugs driven by advanced synthetic biology technologies. The company has a strong management team with extensive experience in multinational research and commercialization. Its flagship product, Youtidelong, has been recognized for its innovative contributions and has received multiple accolades, including FDA orphan drug designation. The company actively seeks partnerships to enhance its business development and clinical recruitment efforts.Explore more
Popular SearchesBiostar Pharma IncBiostar TechnologiesBeijing Biostar Pharmaceuticals CoBeijing Biostar Technologies LtdChengdu Biostar Pharmaceuticals Co LtdSIC Code 28,283NAICS Code 32,325Show moreBiostar Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biostar Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Biostar Pharma is spiking on competitors!
Check if Biostar Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Biostar Pharma recently announced quarterly report
Funding: Get notified immidiatlly once Biostar Pharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Biostar Pharma
Click to see if Biostar Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Biostar Pharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Biostar Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Biostar Pharma
Find more new buyers
Compare Similar Companies to Biostar Pharma
Compare insights from companies similar to Biostar Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Biostar Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biostar Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biostar Pharma.
Biostar Pharma Tech Stack
A closer look at the technologies used by Biostar Pharma
Biostar Pharma News & Media
The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer
SAN FRANCISCO, Sept. 25, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the US wholly-owned subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd. ("Biostar," stock code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and...Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2)
SAN FRANCISCO, Sept. 15, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. ("Biostar", Stock Code: 2563.HK) which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of...Biostar Announces Completion of Patient Recruitment for US Phase 1 Clinical Study of Utidelone Capsule
SAN FRANCISCO, Sept. 3, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the discovery, development and commercialization of innovative oncology drugs, is pleased to announce that subject recruitment of a US Phase 1 clinical study of Utidelone Capsule (UTD2), a company's key pipeline product, for advanced solid tumors (NCT05681000) has been completed. This study is an open-lBiostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis
SAN FRANCISCO, July 5, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Biostar), which is a synthetic biology-driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their core pipeline product Utidelone Injection (UTD1) had been granted to conduct a phase 2 study (BG01-2402) for HER2- breast cancer brain metastasis (BCBM) by the US FDA. Depending on the molecular cl
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biostar Pharma
Sign Up For FreeTo access detailed company insights
Beijing Huahao Zhongtian Biopharmaceutical Co., Ltd. is a comprehensive biopharmaceutical company focused on the research, development, production, and commercialization of innovative anti-tumor drugs driven by advanced synthetic biology technologies. The company has a strong management team with extensive experience in multinational research and c... Read More
